Onctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition: Geneva, Switzerland Friday, December 5, 2025, 15: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback